Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.168 Q1 | 103 | 156 | 307 | 20941 | 1976 | 293 | 5.03 | 134.24 | 43.51 | |
2 | Current Vascular Pharmacology | journal | 0.917 Q1 | 69 | 60 | 187 | 4056 | 722 | 153 | 3.99 | 67.60 | 34.87 | |
3 | Current Medicinal Chemistry | journal | 0.776 Q2 | 202 | 335 | 1214 | 38296 | 5236 | 1130 | 3.90 | 114.32 | 43.21 | |
4 | Current Molecular Pharmacology | journal | 0.694 Q2 | 49 | 71 | 166 | 7930 | 517 | 157 | 2.67 | 111.69 | 45.19 | |
5 | Current Cancer Drug Targets | journal | 0.687 Q2 | 103 | 69 | 228 | 5875 | 726 | 219 | 2.97 | 85.14 | 41.03 | |
6 | Current Drug Targets | journal | 0.621 Q2 | 119 | 110 | 419 | 12345 | 1457 | 403 | 3.15 | 112.23 | 37.65 | |
7 | Journal of Toxicology | journal | 0.614 Q2 | 47 | 39 | 86 | 2062 | 344 | 85 | 3.18 | 52.87 | 36.87 | |
8 | Current Pharmaceutical Design | journal | 0.580 Q2 | 183 | 329 | 1399 | 30311 | 4728 | 1281 | 3.02 | 92.13 | 39.21 | |
9 | CNS and Neurological Disorders - Drug Targets | journal | 0.574 Q2 | 96 | 81 | 217 | 8156 | 639 | 205 | 2.86 | 100.69 | 38.48 | |
10 | International Journal of Genomics | journal | 0.574 Q2 | 37 | 36 | 172 | 1902 | 530 | 170 | 2.92 | 52.83 | 44.68 | |
11 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q2 | 107 | 162 | 450 | 17321 | 1925 | 442 | 3.98 | 106.92 | 41.82 | |
12 | Current Gene Therapy | journal | 0.564 Q2 | 80 | 36 | 122 | 3105 | 438 | 107 | 3.32 | 86.25 | 42.39 | |
13 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q2 | 52 | 35 | 97 | 3255 | 293 | 92 | 2.72 | 93.00 | 50.89 | |
14 | Current Topics in Medicinal Chemistry | journal | 0.516 Q2 | 133 | 191 | 680 | 19008 | 1979 | 550 | 2.79 | 99.52 | 43.40 | |
15 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.428 Q3 | 108 | 286 | 635 | 21787 | 1751 | 622 | 2.76 | 76.18 | 45.09 | |
16 | Current Drug Delivery | journal | 0.391 Q2 | 72 | 87 | 292 | 5415 | 902 | 280 | 2.52 | 62.24 | 39.90 | |
17 | Current Radiopharmaceuticals | journal | 0.379 Q3 | 32 | 38 | 99 | 1789 | 195 | 87 | 1.75 | 47.08 | 43.56 | |
18 | Reviews on Recent Clinical Trials | journal | 0.377 Q3 | 35 | 46 | 136 | 1902 | 226 | 119 | 1.60 | 41.35 | 41.61 | |
19 | Medicinal Chemistry | journal | 0.324 Q3 | 50 | 83 | 270 | 4451 | 570 | 264 | 2.07 | 53.63 | 42.02 | |
20 | Current Drug Safety | journal | 0.318 Q3 | 41 | 55 | 117 | 1784 | 173 | 113 | 1.51 | 32.44 | 49.03 | |
21 | Current Nanoscience | journal | 0.284 Q3 | 52 | 64 | 236 | 5132 | 387 | 228 | 1.65 | 80.19 | 36.89 | |
22 | Combinatorial Chemistry and High Throughput Screening | journal | 0.271 Q3 | 70 | 227 | 359 | 11817 | 560 | 333 | 1.65 | 52.06 | 40.67 | |
23 | Current Computer-Aided Drug Design | journal | 0.258 Q3 | 32 | 42 | 195 | 1983 | 312 | 187 | 1.66 | 47.21 | 45.93 | |
24 | Letters in Drug Design and Discovery | journal | 0.192 Q3 | 37 | 89 | 355 | 4304 | 346 | 329 | 1.00 | 48.36 | 36.31 | |
25 | Current Pharmaceutical Analysis | journal | 0.178 Q3 | 27 | 88 | 340 | 4225 | 222 | 335 | 0.64 | 48.01 | 44.69 | |
26 | Current Drug Therapy | journal | 0.169 Q3 | 20 | 35 | 114 | 1963 | 79 | 111 | 0.70 | 56.09 | 41.67 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®